In the News

Ian de Boer, MD, MS, to be the next Director of the Kidney Research Institute 

We are pleased to announce that Dr. de Boer will assume the leadership role effective May 2, 2022

The Kidney Research Institute was established in 2008 as a collaboration between UW Medicine and the Northwest Kidney Centers with the mission to conduct research to improve the lives of people with kidney diseases. Over these first 14 years, the KRI has substantially exceeded all expectations. The KRI has catalyzed cross-disciplinary collaborations across UW. It is now recognized worldwide for conducting a wide range of high-impact patient-oriented research, spanning basic understanding of kidney physiology and pharmacology, application of cutting-edge innovative technology, high-impact clinical trials, and advancement of person-centered care for people living with kidney diseases.

deBoer
Ian de Boer, MD, MS

Dr. de Boer is a highly acclaimed researcher recognized worldwide for his expertise in diabetic kidney disease and vitamin D metabolism. A native of the Pacific Northwest, Ian underwent his medical schooling at the Oregon Health Sciences University and his residency training at the University of California San Francisco, where he received the Jeffrey Weingarten Award for outstanding third-year medical resident.

We were fortunate to recruit him to UW in 2003 for his Nephrology fellowship training, which included research training in Metabolism, Endocrinology, and Nutrition under the mentorship of John Brunzell. He continued as a faculty member in the Division of Nephrology, funded first through Roadmap K12 and ITHS KL2 Career Development Awards and then continuous support from multiple NIH research project grants. He was honored with the DOM Fialkow award in 2011, promoted to Professor of Medicine in 2017, and inducted into the American Society of Clinical Investigation in 2018. He was appointed Associated Director of the KRI in 2016. In addition to his own high-impact research, he has mentored over 20 trainees, within and outside of Nephrology. 

Dr. de Boer has been a standing member of two NIH study sections (KNOD, PBKD), serves as Deputy Editor of a leading Nephrology journal (Clinical Journal of American of Nephrology), and is Co-Chair of the international KDIGO Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. He is a highly sought speaker and collaborator worldwide. 

Please join us in congratulating Dr. de Boer and supporting him to take the KRI to even greater heights!

KRI Logo